You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 267 No. 13, April 1, 1992 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Board of Trustees Report
 This Article
 •References
 •Full text PDF
 •Correction
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Requirements or Incentives by Government for the Use of Long-Acting Contraceptives

Board of Trustees, American Medical Association

Scott L. Bernstein; Lonnie R. Bristow, MD (Executive Committee); John L. Clowe, MD (President-Elect); Mary Ann Contogiannis, MD (Resident Trustee); Greenville, NC; Richard F. Corlin, MD (Vice Speaker); Nancy W. Dickey, MD (Executive Committee); Palma E. Formica, MD; New Brunswick, NJ; William E. Jacott, MD; Daniel H. Johnson, Jr, MD (Speaker); Robert E. McAfee, MD (Vice Chair); Joseph T. Painter, MD (Chair); Thomas R. Reardon, MD; John J. Ring, MD (President); Raymond Scalettar, MD (Secretary-Treasurer); Jerald R. Schenken, MD; John P. Seward, MD; C. John Tupper, MD (Immediate Past President); Frank B. Walker, MD; Percy Wootton, MD; Dick K. Cason, MD; Frederick W. Cheney, MD; Clarence H. Denser, Jr, MD; Raymond C. Grandon, MD (Chair); Francis X. Lieb, MD; John A. Martin, MD; Eugene S. Ogrod II, MD; David Orentlicher, MD, JD (Secretary); Anita K. Schweickart; David Orentlicher, MD, JD.

JAMA. 1992;267(13):1818-1821.


Abstract

Following the approval of the long-acting contraceptive levonorgestrel (the Norplant Contraceptive System) for use by women, government officials have requi-ed or proposed uses of levonorgestrel that are problematic. One court ordered a woman convicted of child abuse to use levonorgestrel as a condition of her probation; legislators have proposed that women on welfare be paid to use levonorgestrel. Court-ordered use of long-acting contraceptives because of child abuse raises serious questions about a person's fundamental rights to refuse medical treatment, to be free of cruel and unusual punishment, and to procreate. The state's compelling interest in protecting children from abuse may be served by less intrusive means than imposing contraception on parents who have committed child abuse. If government benefits were based on the use of long-acting contraceptives, individuals would have to assume a potentially serious health risk before receiving their benefits. Government benefits should not be made contingent on the acceptance of a health risk.

(JAMA. 1992;267:1818-1821)



Author Affiliations

Chicago, Ill; San Pablo, Calif; Englewood, Fla; Santa Monica, Calif; Richmond, Tex; Minneapolis, Minn; Metairie, La; South Portland, Me; Houston, Tex; Portland, Ore; Mundelein, Ill; Washington, DC; Omaha, Neb; Rockford, Ill; Davis, Calif; Grosse Pointe Farms, Mich; Richmond, Va.; Hillsboro, Tex; Seattle, Wash; Des Moines, Iowa; Harrisburg, Pa; Richmond, Va; Roanoke, Va; Sacramento, Calif; Chicago, Ill; (Associate Secretary), Chicago, Ill.

From the Board of Trustees, American Medical sociation, Chicago, Ill.


Footnotes

This report is revised from Report EE, adopted by the House of Delegates of the American Medical Association at the December 1991 Interim Meeting.

Reprint requests to Office of the General Counsel, American Medical Association, 515 N State St, Chicago, IL 60610 (David Orentlicher, MD, JD).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Physicians' Experience with Norplant(R) Implantable Contraceptives in Finland
Ollila et al.
Scand J Public Health 1995;23:47-52.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1992 American Medical Association. All Rights Reserved.